Bionomics Ltd
ASX:BNO
Balance Sheet
Balance Sheet Decomposition
Bionomics Ltd
Bionomics Ltd
Balance Sheet
Bionomics Ltd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
22
|
5
|
5
|
45
|
43
|
25
|
14
|
5
|
28
|
34
|
|
| Cash |
5
|
5
|
5
|
20
|
42
|
25
|
14
|
5
|
28
|
34
|
|
| Cash Equivalents |
17
|
0
|
0
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
4
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
8
|
29
|
9
|
11
|
10
|
9
|
9
|
3
|
1
|
7
|
|
| Accounts Receivables |
7
|
28
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
9
|
10
|
9
|
8
|
8
|
3
|
1
|
7
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
2
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
|
| Total Current Assets |
31
|
40
|
38
|
58
|
54
|
36
|
25
|
8
|
31
|
42
|
|
| PP&E Net |
1
|
1
|
3
|
3
|
3
|
3
|
3
|
1
|
1
|
1
|
|
| PP&E Gross |
1
|
1
|
3
|
3
|
3
|
3
|
3
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
3
|
3
|
4
|
4
|
2
|
2
|
0
|
|
| Intangible Assets |
17
|
15
|
17
|
16
|
14
|
14
|
13
|
12
|
10
|
10
|
|
| Goodwill |
5
|
9
|
10
|
12
|
12
|
12
|
13
|
13
|
12
|
13
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
5
|
9
|
10
|
12
|
12
|
12
|
13
|
13
|
12
|
13
|
|
| Total Assets |
54
N/A
|
65
+21%
|
69
+6%
|
90
+30%
|
84
-6%
|
65
-23%
|
54
-18%
|
34
-36%
|
54
+57%
|
65
+20%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3
|
3
|
4
|
3
|
2
|
4
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
1
|
3
|
4
|
5
|
3
|
4
|
4
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
5
|
3
|
8
|
6
|
8
|
6
|
0
|
0
|
|
| Other Current Liabilities |
1
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
9
|
14
|
11
|
14
|
13
|
14
|
8
|
2
|
3
|
|
| Long-Term Debt |
0
|
1
|
9
|
18
|
10
|
16
|
10
|
6
|
1
|
1
|
|
| Deferred Income Tax |
0
|
4
|
6
|
5
|
5
|
3
|
3
|
2
|
2
|
2
|
|
| Other Liabilities |
6
|
6
|
9
|
11
|
15
|
16
|
11
|
5
|
2
|
3
|
|
| Total Liabilities |
12
N/A
|
20
+66%
|
37
+84%
|
46
+23%
|
44
-4%
|
48
+10%
|
37
-23%
|
22
-41%
|
7
-69%
|
8
+26%
|
|
| Equity | |||||||||||
| Common Stock |
111
|
112
|
112
|
134
|
135
|
135
|
145
|
148
|
190
|
218
|
|
| Retained Earnings |
71
|
68
|
84
|
95
|
99
|
124
|
135
|
142
|
148
|
167
|
|
| Other Equity |
1
|
1
|
4
|
5
|
5
|
6
|
6
|
6
|
5
|
6
|
|
| Total Equity |
41
N/A
|
45
+8%
|
32
-29%
|
44
+38%
|
40
-8%
|
17
-58%
|
16
-3%
|
13
-23%
|
48
+275%
|
57
+20%
|
|
| Total Liabilities & Equity |
54
N/A
|
65
+21%
|
69
+6%
|
90
+30%
|
84
-6%
|
65
-23%
|
54
-18%
|
34
-36%
|
54
+57%
|
65
+20%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
416
|
417
|
418
|
552
|
553
|
554
|
625
|
719
|
1 008
|
1 353
|
|